VEGF Anticorpos
| Empty Table Header | Nome do Produto | CATALOG # | Isótopo | Epitopo | Aplicacao | Species | Uso e aplicacao | NOTAS |
|---|---|---|---|---|---|---|---|---|
VEGF Anticorpo (C-1) | sc-7269 | mouse IgG1 κ | 1-140 (h) | WB, IP, IF, IHC(P) | m, r, h | 1,262 | ||
VEGF Anticorpo (JH121) | sc-57496 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 86 | ||
VEGF Anticorpo (VG-1) | sc-53462 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P) | m, r, h and canine | 97 | ||
VEGF Anticorpo (F-5) | sc-365578 | mouse IgM κ | N-Terminal (h) | WB, IP, IF, ELISA | m, r, h | 18 | ||
VEGF Anticorpo (VG76e) | sc-53463 | mouse IgG1 κ | (h) | WB, IP, IF | m, r, h | 1 | ||
VEGF-B Anticorpo (RM0008-6E72) | sc-101582 | rat IgG2 | (m) | WB, IP, IF, IHC(P) | m, r, h | 2 | ||
VEGF-B Anticorpo (56-1) | sc-81670 | mouse IgG1 κ | C-Terminal (h) | WB, IP, IF | m, r, h | 7 | ||
VEGF-B Anticorpo (MM0008-7B43) | sc-101581 | mouse IgG1 | (h) | WB, IP, IF | h | 1 | ||
VEGF-C Anticorpo (E-6) | sc-374628 | mouse IgG2a κ | 103-137 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 29 | ||
VEGF-C Anticorpo (F-10) | sc-74585 | mouse IgG2a κ | 230-419 (h) | WB, IP, IF, ELISA | m, r, h | 4 | ||
VEGF-C Anticorpo (A-5) | sc-74584 | mouse IgM κ | 230-419 (h) | WB, IP, IF, ELISA | m, r, h | 3 | ||
VEGF-C Anticorpo (30AT1174.77.260) | sc-130289 | mouse IgG1 | C-Terminal (h) | WB, IP, ELISA | m, r, h | 2 | ||
VEGF-C Anticorpo (F-5) | sc-398004 | mouse IgM κ | 29-52 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
VEGF-C Anticorpo (MM0006-2E65) | sc-101583 | mouse IgG2 | (h) | WB, IP, IF, IHC(P) | h | 1 | ||
VEGF-D Anticorpo (C-12) | sc-373866 | mouse IgG1 κ | 330-353 (h) | WB, IP, IF, ELISA | h | 8 | ||
VEGF-D Anticorpo (28AT743.288.48) | sc-517375 | mouse IgG1 | (h) | WB | m, r, h | new | ||
EG-VEGF Anticorpo (E-12) | sc-390741 | mouse IgG2b κ | 66-105 (h) | WB, IP, IF, ELISA | m, r, h | 2 |
VEGF CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Nome do Produto | CATALOG # | Species | Aplicacao | MARCADOR | Uso e aplicacao | NOTAS |
|---|---|---|---|---|---|---|---|
VEGF Plasmídeo CRISPR/Cas9 KO (h2) | sc-400019-KO-2 | h | Gene Knockout | GFP | 1 | ||
VEGFPlasmídeo HDR (h2) | sc-400019-HDR-2 | h | Homology Directed Repair | Puromycin | 1 | ||
VEGF Plasmídeo duplo de Nickase (h) | sc-400019-NIC | h | Gene Knockout | Puromycin | 1 | ||
VEGF Plasmídeo duplo de Nickase (h2) | sc-400019-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
VEGF Plasmídeo CRISPR/Cas9 KO (m) | sc-423665 | m | Gene Knockout | GFP | 1 | ||
VEGF Plasmídeo CRISPR/Cas9 KO (r) | sc-437276 | r | Gene Knockout | GFP | 0 | ||
VEGF Plasmídeo duplo de Nickase (r) | sc-437276-NIC | r | Gene Knockout | Puromycin | 0 | ||
VEGF Plasmídeo duplo de Nickase (r2) | sc-437276-NIC-2 | r | Gene Knockout | Puromycin | 0 | ||
VEGF-B Plasmídeo CRISPR/Cas9 KO (m) | sc-423666 | m | Gene Knockout | GFP | 0 | ||
VEGF-C Plasmídeo CRISPR/Cas9 KO (h2) | sc-400553-KO-2 | h | Gene Knockout | GFP | 0 | ||
VEGF-CPlasmídeo HDR (h2) | sc-400553-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
VEGF-C Plasmídeo duplo de Nickase (h) | sc-400553-NIC | h | Gene Knockout | Puromycin | 0 | ||
VEGF-C Plasmídeo duplo de Nickase (h2) | sc-400553-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
VEGF-C Plasmídeo CRISPR/Cas9 KO (m) | sc-423667 | m | Gene Knockout | GFP | 0 | ||
VEGF-D Plasmídeo CRISPR/Cas9 KO (h) | sc-401669 | h | Gene Knockout | GFP | 0 | ||
VEGF-DPlasmídeo HDR (h) | sc-401669-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
VEGF-D Plasmídeo duplo de Nickase (h) | sc-401669-NIC | h | Gene Knockout | Puromycin | 0 | ||
VEGF-D Plasmídeo duplo de Nickase (h2) | sc-401669-NIC-2 | h | Gene Knockout | Puromycin | 0 |
VEGF CRISPR Activation Products
| Empty Table Header | Nome do Produto | CATALOG # | Species | Aplicacao | MARCADOR | Uso e aplicacao | NOTAS |
|---|---|---|---|---|---|---|---|
EG-VEGF Plasmídeo de ativação de CRISPR (h) | sc-404774-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
VEGF Plasmídeo de ativação de CRISPR (m) | sc-423665-ACT | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
VEGF Plasmídeo de ativação de CRISPR (m2) | sc-423665-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
VEGF Lentiviral Ativação Partículas de ativação de lentivirus (m) | sc-423665-LAC | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
VEGF Lentiviral Ativação Partículas de ativação de lentivirus (m2) | sc-423665-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
VEGF Plasmídeo de ativação de CRISPR (r) | sc-437276-ACT | r | Gene Activation | Puro, Blast, Hygro | 0 | ||
VEGF Plasmídeo de ativação de CRISPR (r2) | sc-437276-ACT-2 | r | Gene Activation | Puro, Blast, Hygro | 0 | ||
VEGF-B Plasmídeo de ativação de CRISPR (h) | sc-401522-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
VEGF-C Plasmídeo de ativação de CRISPR (h) | sc-400553-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
VEGF-C Plasmídeo de ativação de CRISPR (h2) | sc-400553-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
VEGF-C Plasmídeo de ativação de CRISPR (m) | sc-423667-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
VEGF-C Plasmídeo de ativação de CRISPR (m2) | sc-423667-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
VEGF-C Lentiviral Ativação Partículas de ativação de lentivirus (m) | sc-423667-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
VEGF-C Lentiviral Ativação Partículas de ativação de lentivirus (m2) | sc-423667-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
VEGF-D Plasmídeo de ativação de CRISPR (h) | sc-401669-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 |
VEGF siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Nome do Produto | CATALOG # | Species | Aplicacao | MARCADOR | Uso e aplicacao | NOTAS |
|---|---|---|---|---|---|---|---|
EG-VEGF siRNA (h) | sc-45392 | h | Gene Silencing | N/A | 0 | ||
EG-VEGF Plasmídeo shRNA (h) | sc-45392-SH | h | Gene Silencing | Puromycin | 0 | ||
EG-VEGF shRNA (h) Partículas de lentivirus | sc-45392-V | h | Gene Silencing | Puromycin | 0 | ||
EG-VEGF siRNA (m) | sc-45393 | m | Gene Silencing | N/A | 0 | ||
EG-VEGF Plasmídeo shRNA (m) | sc-45393-SH | m | Gene Silencing | Puromycin | 0 | ||
EG-VEGF sarna (m) Partículas de lentivirus | sc-45393-V | m | Gene Silencing | Puromycin | 0 | ||
VEGF siRNA (h) | sc-29520 | h | Gene Silencing | N/A | 39 | ||
VEGF siRNA (h2) | sc-44278 | h | Gene Silencing | N/A | 0 | ||
VEGF Plasmídeo shRNA (h) | sc-29520-SH | h | Gene Silencing | Puromycin | 39 | ||
VEGF Plasmídeo shRNA (h2) | sc-44278-SH | h | Gene Silencing | Puromycin | 0 | ||
VEGF sarna (h) Partículas de lentivirus | sc-29520-V | h | Gene Silencing | Puromycin | 39 | ||
VEGF sarna (h2) Partículas de lentivirus | sc-44278-V | h | Gene Silencing | Puromycin | 0 | ||
VEGF siRNA (m) | sc-36815 | m | Gene Silencing | N/A | 6 | ||
VEGF Plasmídeo shRNA (m) | sc-36815-SH | m | Gene Silencing | Puromycin | 6 | ||
VEGF sarna (m) Partículas de lentivirus | sc-36815-V | m | Gene Silencing | Puromycin | 6 | ||
VEGF-B siRNA (h) | sc-39840 | h | Gene Silencing | N/A | 1 | ||
VEGF-B Plasmídeo shRNA (h) | sc-39840-SH | h | Gene Silencing | Puromycin | 1 | ||
VEGF-B sarna (h) Partículas de lentivirus | sc-39840-V | h | Gene Silencing | Puromycin | 1 | ||
VEGF-B siRNA (m) | sc-39841 | m | Gene Silencing | N/A | 0 | ||
VEGF-B Plasmídeo shRNA (m) | sc-39841-SH | m | Gene Silencing | Puromycin | 0 | ||
VEGF-B sarna (m) Partículas de lentivirus | sc-39841-V | m | Gene Silencing | Puromycin | 0 | ||
VEGF-C siRNA (h) | sc-39842 | h | Gene Silencing | N/A | 3 | ||
VEGF-C Plasmídeo shRNA (h) | sc-39842-SH | h | Gene Silencing | Puromycin | 3 | ||
VEGF-C sarna (h) Partículas de lentivirus | sc-39842-V | h | Gene Silencing | Puromycin | 3 | ||
VEGF-C siRNA (m) | sc-39843 | m | Gene Silencing | N/A | 1 | ||
VEGF-C Plasmídeo shRNA (m) | sc-39843-SH | m | Gene Silencing | Puromycin | 1 | ||
VEGF-C sarna (m) Partículas de lentivirus | sc-39843-V | m | Gene Silencing | Puromycin | 1 | ||
VEGF-D siRNA (h) | sc-39844 | h | Gene Silencing | N/A | 2 | ||
VEGF-D Plasmídeo shRNA (h) | sc-39844-SH | h | Gene Silencing | Puromycin | 2 | ||
VEGF-D sarna (h) Partículas de lentivirus | sc-39844-V | h | Gene Silencing | Puromycin | 2 | ||
VEGF-D siRNA (m) | sc-39845 | m | Gene Silencing | N/A | 0 | ||
VEGF-D Plasmídeo shRNA (m) | sc-39845-SH | m | Gene Silencing | Puromycin | 0 | ||
VEGF-D shRNA (m) Partículas de lentivirus | sc-39845-V | m | Gene Silencing | Puromycin | 0 |
VEGF Proteins
| Empty Table Header | Nome do Produto | CATALOG # | Quantia | Species | Uso e aplicacao | NOTAS |
|---|---|---|---|---|---|---|
VEGF (hBA-165) | sc-4570 | 50 µg | h | 7 | ||
VEGF (mBA-165) | sc-4571 | 50 µg | m | 10 |